drugset / Trial / NCT00014105

Combination Chemotherapy in Treating Patients With Recurrent Glioblastoma Multiforme

NCT00014105

Phase 1/2 Unknown Atlantic Health System
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of combination chemotherapy in treating patients who have recurrent glioblastoma multiforme.

Timeline

Start
2000-12
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule Intravenous
Subject Temozolomide Small molecule Oral